Agios cashes in on cancer drug again with $905M Royalty Pharma deal

Agios cashes in on cancer drug again with $905M Royalty Pharma deal

Submitted by admin on May 28, 2024 - 10:33pm
Source: 
BioPharma Dive
News Tags: 
Agios Pharma
Royalty Pharma
brain cancer
Servier
vorasidenib
Headline: 
Agios cashes in on cancer drug again with $905M Royalty Pharma deal
snippet: 

Agios Pharmaceuticals has agreed to sell to Royalty Pharma rights to royalties on a brain cancer drug it invented and sold to Servier.

Do Not Allow Advertisers to Use My Personal information